Imabiotech boosts its strategic partnerships

Imabiotech, a French CRO based in Lille (France) and in Boston (USA), is expanding its range of services. This company is offering innovative imaging services and software to the pharmaceutical research sector.  These services are based on histology combined to label free molecular imaging (Quantitative Mass Spectrometry Imaging, QMSI) . This technology…..

Trend Chart on Microbiota – January 16, 2019

FEATURE STORY ●  AllergoOncology: microbiota in allergy and cancer - an EAACI position paper BASIC SCIENCE ● The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients ● Effect of the nursing mother on the gut microbiome of the offspring during early mouse development ● Enhancement of the gut barrier integrity by…..


RNA science is now translated into new therapies… Last August, the FDA approved the first RNAi therapy, Onpattro®… RNA drugs allow precised silencing or activation of genes… RNA drugs can address a wide range of common and rare diseases… More than 60 rare or common diseases are currently  targeted….  BioPharmAnalyses…..